The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic…

Two drugs are being trialled in the Ituri region in a programme set up just six weeks after the outbreak was declared, with hopes it will reduce mortality rates

The Democratic Republic of the Congo has launched a record-breaking trial for two drugs, enrolling patients just six weeks after an outbreak was declared in the Ituri region.

First patients have been enrolled in a Ebola treatment trial in the Democratic Republic of Congo as two drugs are being trialed in the Ituri region in a program set up just six…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleThe University of Oxford is set to begin…

Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain

Oxford's Ebola vaccine candidate has entered Phase 1 clinical trials for safety evaluation. The ChAdOx1 BDBV vaccine uses a platform similar to the Covid-19 vaccine. Serum…

Scientists in Oxford will start to test the world's first vaccine against Bundibugyo Ebola, as an outbreak of the rare virus strain continues to spread across Congo and Uganda.

The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of…

Scientists have launched the first clinical trial to test whether an experimental antiviral pill can prevent Bundibugyo Ebola after exposure, offering hope for a new…